AAAAAA

   
Results: 1-13 |
Results: 13
Antigen-specific immunomodulation via altered peptide ligands
Authors: Bielekova, B Martin, R
Citation: B. Bielekova et R. Martin, Antigen-specific immunomodulation via altered peptide ligands, J MOL MED-J, 79(10), 2001, pp. 552-565
Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS lyme disease
Authors: Martin, R Gran, B Zhao, YD Markovic-Plese, S Bielekova, B Marques, A Sung, MH Hemmer, B Simon, R McFarland, HF Pinilla, C
Citation: R. Martin et al., Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS lyme disease, J AUTOIMMUN, 16(3), 2001, pp. 187-192
Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes
Authors: Wandinger, KP Sturzebecher, CS Bielekova, B Detore, G Rosenwald, A Staudt, LM McFarland, HF Martin, R
Citation: Kp. Wandinger et al., Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes, ANN NEUROL, 50(3), 2001, pp. 349-357
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (vol 6, pg 1167, 2000)
Authors: Bielekova, B Goodwin, B Richert, N Cortese, I Kondo, T Afshar, G Gran, B Eaton, J Antel, J Frank, JA McFarland, HF Martin, R
Citation: B. Bielekova et al., Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (vol 6, pg 1167, 2000), NAT MED, 6(12), 2000, pp. 1412-1412
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
Authors: Bielekova, B Goodwin, B Richert, N Cortese, I Kondo, T Afshar, G Gran, B Eaton, J Antel, J Frank, JA McFarland, HF Martin, R
Citation: B. Bielekova et al., Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand, NAT MED, 6(10), 2000, pp. 1167-1175
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis
Authors: Muraro, PA Leist, T Bielekova, B McFarland, HF
Citation: Pa. Muraro et al., VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis, J NEUROIMM, 111(1-2), 2000, pp. 186-194
Mechanisms of immunomodulation by glatiramer acetate
Authors: Gran, B Tranquill, LR Chen, M Bielekova, B Zhou, W Dhib-Jalbut, S Martin, R
Citation: B. Gran et al., Mechanisms of immunomodulation by glatiramer acetate, NEUROLOGY, 55(11), 2000, pp. 1704-1714
Myelin-associated oligodendrocytic basic protein: Identification of an encephalitogenic epitope and association with multiple sclerosis
Authors: Holz, A Bielekova, B Martin, R Oldstone, MBA
Citation: A. Holz et al., Myelin-associated oligodendrocytic basic protein: Identification of an encephalitogenic epitope and association with multiple sclerosis, J IMMUNOL, 164(2), 2000, pp. 1103-1109
Therapeutic potential of phosphodiesterase-4 and-3 inhibitors in Th1-mediated autoimmune diseases
Authors: Bielekova, B Lincoln, A McFarland, H Martin, R
Citation: B. Bielekova et al., Therapeutic potential of phosphodiesterase-4 and-3 inhibitors in Th1-mediated autoimmune diseases, J IMMUNOL, 164(2), 2000, pp. 1117-1124
Human autoreactive CD4(+) T cells from naive CD45RA(+) and memory CD45RO(+) subsets differ with respect to epitope specificity and functional antigenavidity
Authors: Muraro, PA Pette, M Bielekova, B McFarland, HF Martin, R
Citation: Pa. Muraro et al., Human autoreactive CD4(+) T cells from naive CD45RA(+) and memory CD45RO(+) subsets differ with respect to epitope specificity and functional antigenavidity, J IMMUNOL, 164(10), 2000, pp. 5474-5481
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease
Authors: Hemmer, B Gran, B Zhao, YD Marques, A Pascal, J Tzou, A Kondo, T Cortese, I Bielekova, B Straus, SE McFarland, HF Houghten, R Simon, R Pinilla, C Martin, R
Citation: B. Hemmer et al., Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease, NAT MED, 5(12), 1999, pp. 1375-1382
The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment ofmultiple sclerosis
Authors: Jiang, H Bielekova, B Okazaki, H Clarence-Smith, K Johnson, KP Bergey, G Martin, R Dhib-Jalbut, S
Citation: H. Jiang et al., The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment ofmultiple sclerosis, J NEUROIMM, 97(1-2), 1999, pp. 134-145
Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7
Authors: Bielekova, B Muraro, PA Golestaneh, L Pascal, J McFarland, HF Martin, R
Citation: B. Bielekova et al., Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7, J NEUROIMM, 100(1-2), 1999, pp. 115-123
Risultati: 1-13 |